CDNA vs ADPT

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

CDNA

24.9
AI Score
VS
ADPT Wins

ADPT

44.6
AI Score

Investment Advisor Scores

CDNA

25score
Recommendation
SELL

ADPT

45score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CDNA ADPT Winner
Revenue 389.01M 226.33M CDNA
Net Income 132.74M -56.95M CDNA
Net Margin 34.1% -25.2% CDNA
Operating Income 122.53M -35.43M CDNA
ROE 28.4% -32.3% CDNA
ROA 20.7% -8.3% CDNA
Total Assets 641.46M 683.12M ADPT
Cash 250.48M 75.61M CDNA
Current Ratio 2.31 3.97 ADPT
Free Cash Flow 40.36M -10.24M CDNA

Relative Price Performance (Last 90 Days)

CDNA 1M: +28.0% · 3M: +70.7% ADPT 1M: +14.8% · 3M: +16.3%

Current Technical Phase

CDNA

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (20.0% over 20 days), RSI 59

RSI (14): 59.2 · Price: $80.77

ADPT

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (1.9% over 20 days), RSI 60

RSI (14): 60.3 · Price: $29.36

Fundamentals Snapshot

Metric CDNA ADPT
Market Cap — —
Forward P/E 51.2 -279.6
Trailing P/E 35.6 —
Revenue (TTM) — —
Revenue Growth 0.4% -0.1%
Gross Margin 0.7% 0.5%
Operating Margin 0.1% 0.0%
EPS 2.37 -0.45
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, ADPT is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.